ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 36373 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 36373; 2) Community: the network communities that were significantly associated with the response to NSC 36373; 3) Molecule: the relationships between components within communities and NSC 36373; 4) MDR: the compounds that were significantly associated with the NSC 36373.

NSC Compound Enrichment Correlation
NSC 720147 Null 0.0102077332082016 0.22619657
NSC 720194 Null 0.0102077332082016 -0.076585985
NSC 724330 Aminopyrimidine-CH3 0.0102077332082016 0.37781901
NSC 735372 Bis{(5,6-dihydro-5,11-diketo-2,3-dimethoxy-11H-indeno[1,2-c] isoquinoline)-6-ethylamino}propane Bis(trifluoroacetate) 0.0102077332082016 0.28546842
NSC 756169 GSK317314A 0.0102077332082016 0.58963
NSC 761834 (Z)-5-chloro-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.0102077332082016 0.028319676
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0102077332082017 0.45046931
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0102077332082017 0.49958884
NSC 180973 Tamoxifen citrate 0.0102077332082017 0.36368656
NSC 220334 Replaced CAS registry number(s): 66835-31-2 0.0102077332082017 0.34957944
Total:129  Current:38    [First] [Prev] [Next] [Last]